| Weight | 656.662 g/mol |
|---|---|
| Formula | C32H32O13S |
| Hydrogen Acceptors | 14 |
| Hydrogen Donors | 3 |
| Aromatic Rings | 3 |
| Rotatable Bonds | 6 |
Teniposido (29767-20-2)
Teniposide · Vumon · VM26
Score:
#465 in Biochemistry
,
#1494 in Biology
,
#1755 in Chemistry
"What do you need help with?"
LabBot
- Sigma-Aldrich - Search for Teniposido
- Fisher Scientific - Search for Teniposido
- TCI - Search for Teniposido
- Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. (Journal of Clinical Oncology, 1998)
- Atypical Multiple Drug Resistance in a Human Leukemic Cell Line Selected for Resistance to Teniposide (VM-26) (Cancer Research, 1987)
- The clinical pharmacology of etoposide and teniposide. (Clinical Pharmacokinectics, 1987)
- Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. (Journal of Clinical Oncology, 1994)
- Treatment of Brain Metastases of Small-Cell Lung Cancer: Comparing Teniposide and Teniposide With Whole-Brain RadiotherapyA Phase III Study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group (Journal of Clinical Oncology, 2000)
- Single- and Double-Strand DNA Breakage and Repair in Human Lung Adenocarcinoma Cells Exposed to Etoposide and Teniposide (Cancer Research, 1985)
-
Predict GHS Hazards for Any Chemical in silico.
Including Acute Oral Tox, Skin Sensitization, Eye Irritation, Aquatic Tox, & more. - H341: Suspected of causing genetic defects
Warning Germ cell mutagenicity - Category 2 - H361: Suspected of damaging fertility or the unborn child
Warning Reproductive toxicity - Category 2 - H372: Causes damage to organs through prolonged or repeated exposure
Danger Specific target organ toxicity, repeated exposure - Category 1 - Teniposide
- Vumon
- VM26
- VM 26
- VM-26
- NSC-122819
- NSC 122819
- Demethyl Epipodophyllotoxin Thenylidine Glucoside
- NSC122819
- Teniposide, (5a alpha,9 alpha(S*))-Isomer
-
SMILESCOC1=CC(=CC(=C1O)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O
-
InChIKeyNRUKOCRGYNPUPR-UHFFFAOYSA-N
- Pubchem - Teniposido
- Wikipedia - teniposide
Teniposide (trade name Vumon) is a chemotherapeutic medication used in the treatment of childhood acute lymphocytic leukemia (ALL), Hodgkin's lymphoma, certain brain tumours, and other types of cancer. It is in a class of drugs known as podophyllotoxin derivatives and slows the growth of cancer cells in the body.
Suppliers
Most-cited Publications
Areas of Application
Safety
Trends
Alternate Names
External Links
Similar Compounds
CARMINIC ACID
(1390-65-4, 1260-17-9)
11 alternate names
3 suppliers
Carmine
(1390-65-4, 1260-17-9, 1343-78-8)
11 alternate names
3 suppliers
CARMINIC ACID
(1390-65-4, 1260-17-9)
11 alternate names
3 suppliers
Carmine
(1390-65-4, 1260-17-9)
11 alternate names
3 suppliers
Phlorizin
(7061-54-3, 60-81-1)
11 alternate names
3 suppliers
salmeterol xinafoate
(94749-08-3)
11 alternate names
3 suppliers
Tolterodine tartrate
(124937-52-6)
11 alternate names
3 suppliers
Baicalin
(21967-41-9)
11 alternate names
3 suppliers
aloin
(5133-19-7, 8015-61-0)
11 alternate names
3 suppliers
Solvent green 3
(128-80-3)
11 alternate names
3 suppliers
Difenacoum
(56073-07-5)
11 alternate names
3 safety hazards
3 suppliers
Flufenoxuron
(101463-69-8)
11 alternate names
2 safety hazards
3 suppliers
CYTOCHALASIN B
(14930-96-2)
11 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
11 alternate names
3 suppliers
14930-96-2
(14930-96-2)
11 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
11 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
11 alternate names
3 suppliers
CYTOCHALASIN B
(14930-96-2)
11 alternate names
3 suppliers
METHYLPREDNISOLONE HEMISUCCINATE
(2921-57-5)
11 alternate names
3 suppliers
25653-16-1
(25653-16-1)
11 alternate names
3 suppliers
vitamin e succinate
(4345-03-3, 17407-37-3)
11 alternate names
3 suppliers
Estrone 3-glucuronide
(2479-90-5)
11 alternate names
3 suppliers
LUTEOSKYRIN
(21884-44-6)
11 alternate names
3 suppliers
BRODIFACOUM
(56073-10-0)
11 alternate names
3 safety hazards
3 suppliers
ZOLPIDEM TARTRATE
(99294-93-6)
11 alternate names
3 suppliers
Bispyribac
(125401-75-4)
11 alternate names
3 suppliers
Indoxacarb
(173584-44-6)
11 alternate names
5 safety hazards
3 suppliers
Trixylenyl phosphate
(25155-23-1, 3862-12-2)
11 alternate names
3 suppliers
Vitamin E acetate
(7695-91-2, 52225-20-4, 58-95-7)
11 alternate names
3 suppliers
Leu-enkephalin
(14-18-6, 58822-25-6, 59141-40-1)
11 alternate names
3 suppliers
Convallatoxin
(508-75-8)
11 alternate names
3 suppliers
Meclizine dihydrochloride
(1104-22-9, 31884-77-2)
11 alternate names
3 suppliers
Convallaotoxin
(5822-57-1)
11 alternate names
3 suppliers
Canthaxanthin
(514-78-3)
11 alternate names
3 suppliers
alpha-tochopheryl acetate
(7695-91-2, 58-95-7)
11 alternate names
3 suppliers
GLYCOGEN
(9005-79-2)
11 alternate names
3 suppliers
65181-78-4
(65181-78-4)
11 alternate names
2 safety hazards
3 suppliers
PAMOIC ACID
(130-85-8)
11 alternate names
3 suppliers
3236-71-3
(3236-71-3)
11 alternate names
3 safety hazards
3 suppliers
Bromadiolone
(28772-56-7)
11 alternate names
3 suppliers
sulfasalazine
(599-79-1)
11 alternate names
3 suppliers
sulfasalazine
(599-79-1)
11 alternate names
3 suppliers
sulfasalazine
(599-79-1)
11 alternate names
3 suppliers
streptomycin
(3810-74-0, 57-92-1)
11 alternate names
3 suppliers
Raticate
(991-42-4)
11 alternate names
1 safety hazard
3 suppliers
Capsanthin
(465-42-9)
11 alternate names
3 suppliers
NSC101316
(991-42-4)
11 alternate names
1 safety hazard
3 suppliers
CAS Directory
